SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007798
Filing Date
2022-05-05
Accepted
2022-05-05 16:03:17
Documents
80
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q inva-20220331.htm   iXBRL 10-Q 2773295
2 EX-31.1 inva-ex31_1.htm EX-31.1 15798
3 EX-31.2 inva-ex31_2.htm EX-31.2 15801
4 EX-32 inva-ex32.htm EX-32 26146
  Complete submission text file 0000950170-22-007798.txt   12479079

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20220331_pre.xml EX-101.PRE 532251
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20220331.xsd EX-101.SCH 69197
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inva-20220331_lab.xml EX-101.LAB 550642
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20220331_cal.xml EX-101.CAL 92594
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20220331_def.xml EX-101.DEF 410159
74 EXTRACTED XBRL INSTANCE DOCUMENT inva-20220331_htm.xml XML 2656293
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 22896084
SIC: 2834 Pharmaceutical Preparations